Goodwin, Davis Polk Lead Avalyn's Upsized $300M IPO
By Jade Martinez-Pogue · April 30, 2026, 4:34 PM EDT
Biotechnology firm Avalyn Pharma Inc. began trading publicly Thursday after raising $300 million in an upsized initial public offering....
To view the full article, register now.